GMP Certified Finished Medicines Paracetamol Injection 300mg/2ml Shinepharm

Product Details
Customization: Available
Application: Internal Medicine
Usage Mode: Injection
Still deciding? Get samples of US$ 0/box
Request Sample
Manufacturer/Factory, Trading Company

360° Virtual Tour

Diamond Member Since 2015

Suppliers with verified business licenses

Audited Supplier

Audited by an independent third-party inspection agency

Management System Certification
ISO 9001, GMP, ISO 13485, FSC
Import & Export Mode
Have Own Export License
  • GMP Certified Finished Medicines Paracetamol Injection 300mg/2ml Shinepharm
  • GMP Certified Finished Medicines Paracetamol Injection 300mg/2ml Shinepharm
  • GMP Certified Finished Medicines Paracetamol Injection 300mg/2ml Shinepharm
  • GMP Certified Finished Medicines Paracetamol Injection 300mg/2ml Shinepharm
  • GMP Certified Finished Medicines Paracetamol Injection 300mg/2ml Shinepharm
  • GMP Certified Finished Medicines Paracetamol Injection 300mg/2ml Shinepharm
Find Similar Products

Basic Info.

Model NO.
AMC14047-02
State
Liquid
Shape
Injection
Type
Organic Chemicals
Pharmaceutical Technology
Chemical Synthesis
Standard Available
Bp, Cp
Delivery Time
30~60 Days
Transport Package
Carton
Specification
300MG/2ML, 10′ S/BOX
Trademark
Shinepharm, OEM
Origin
China
HS Code
3004909099
Production Capacity
1000000 Boxes/Month

Product Description

 
GMP Certified Finished Medicines Paracetamol Injection 300mg/2ml Shinepharm

Indicatios:
Paracetamol Baxter is indicated for the short-term treatment of moderate pain, especially following surgery and for the short-term treatment of fever, when administration by intravenous route is clinically justified by an urgent need to treat pain or hyperthermia and/or when other routes of administration are not possible.
This medicinal product is indicated in adults, adolescents and children weighing more than 33 kg.

Dosage and administration:
Intravenous use.
This medicinal product is restricted to adults, adolescents and children weighing more than 33 kg.

Drug interactions:
Probenecid causes an almost 2-fold reduction in clearance of paracetamol by inhibiting its conjugation with glucuronic acid. A reduction of the paracetamol dose should be considered for concomitant treatment with probenecid,
▪ Salicylamide may prolong the elimination t1/2 of paracetamol,
▪ Caution should be paid to the concomitant intake of enzyme-inducing substances.
▪ Concomitant use of paracetamol (4 g per day for at least 4 days) with oral anticoagulants may lead to slight variations of INR values. In this case, increased monitoring of INR values should be conducted during the period of concomitant use as well as for 1 week after paracetamol treatment has been discontinued.

Storage:
Do not refrigerate or freeze.
Store the immediate packaging in the outer, over wrap.

 

GMP Certified Finished Medicines Paracetamol Injection 300mg/2ml ShinepharmGMP Certified Finished Medicines Paracetamol Injection 300mg/2ml Shinepharm
GMP Certified Finished Medicines Paracetamol Injection 300mg/2ml ShinepharmGMP Certified Finished Medicines Paracetamol Injection 300mg/2ml ShinepharmGMP Certified Finished Medicines Paracetamol Injection 300mg/2ml ShinepharmGMP Certified Finished Medicines Paracetamol Injection 300mg/2ml ShinepharmGMP Certified Finished Medicines Paracetamol Injection 300mg/2ml Shinepharm

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now
Contact Supplier